Committee advances bill to lower elevated blood-lead threshold to 3.5 µg/dL amid cost concerns

Chair opened discussion of Senate Bill 1816, which would amend the Public Health Law to define an elevated blood-lead level as 3.5 micrograms per deciliter, and said the change aligns with efforts to reduce childhood lead exposure. The Chair called the measure “necessary” and noted the state has passed related bills to identify and replace lead pipes.

A committee member cited an estimate from the New York Association of Counties that putting the threshold at 3.5 µg/dL could cost about $68,600,000 for local implementation and asked why the proposal was not included in the state budget. The committee member said counties already face many unfunded mandates and asked whether the sponsor intended to seek budgetary aid to offset those costs. The committee member said they would support the bill but wanted the fiscal issue addressed going forward.

The Chair acknowledged the fiscal impact and said the bill was a recent addition to the agenda; the Chair noted that existing budget pools for water-quality projects might be available but that it was unclear whether the sponsor planned to include new funding in this year’s budget. “There is certainly a fiscal component,” the Chair said, and added that the matter should be considered in future budget years.

Committee members pressed for clarity about whether the estimate represented the cost of lowering the threshold from 10 µg/dL to 3.5 µg/dL or from 5 µg/dL to 3.5 µg/dL. A committee member summarized the concern as ensuring that counties are not left to shoulder the full cost of implementation.

After discussion, the committee voted to report the bill to First Reading for further consideration.

What’s next: The bill will proceed to First Reading, where fiscal impacts and any budgetary offsets are likely to receive further review.